Company intelligence / Profile preview

Biocompatibles

Oxford, Connecticut, United Statesbiocomplabs.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Biocompatibles developed innovative biopolymer-based medical devices and controlled-release drug delivery systems. Its main commercial focus was on embolization therapies using compressible PVA microspheres and proprietary polymer technologies for targeted cancer treatment. The company also had a significant contact lens business until its sale in 2002. It was acquired by BTG plc in 2010, which itself was acquired by Boston Scientific in 2019. Its core technologies are now part of Boston Scientific's interventional oncology portfolio.

Therapeutic areas
OncologyCardiovascularOphthalmology
Modalities
DevicePolymer-drug conjugate therapy (drug-eluting beads)Small molecule (delivered via embolic microspheres and beads)Biologic (encapsulation technologies for biological agents)
Industry
Therapeutic Medical Devices

Beyond the preview

Go deeper on Biocompatibles.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biocompatibles.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call